Department of Epidemiology, School of Public Health, Southern Medical University, 1838 Guangzhou North Road, Guangzhou, 510515, Guangdong, China.
Department of Laboratory Medicine, Microbiome Medicine Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Cardiovasc Diabetol. 2024 Jul 27;23(1):276. doi: 10.1186/s12933-024-02370-4.
Atherogenic index of plasma (AIP), a marker of atherosclerosis and cardiovascular disease (CVD). However, few studies have investigated association between AIP and all-cause mortality and specific-mortality in the general population.
This study included data from 14,063 American adults. The exposure variable was the AIP, which was defined as log10 (triglycerides/high-density lipoprotein cholesterol). The outcome variables included all-cause mortality and specific-mortality. Survey-weighted cox regressions were performed to evaluate the relation between AIP and all-cause mortality and specific-mortality. Weighted restricted cubic spline was conducted to examin the non-linear relationship.
During 10 years of follow-up, we documented 2,077, 262, 854, and 476 cases of all-cause mortality, diabetes mortality, CVD mortality and cancer mortality, respectively. After adjustment for potential confounders, we found that atherogenic index of plasma (AIP) was significantly associated with an increased risk of diabetes mortality when comparing the highest to the lowest quantile of AIP in female (p for trend = 0.001) or participants older than 65 years (p for trend = 0.002). AIP was not significantly associated with all-cause mortality, CVD mortality and cancer mortality (p > 0.05). Moreover, a non-linear association was observed between AIP and all-cause mortality in a U-shape (p for non-linear = 0.0011), while a linear relationship was observed with diabetes mortality and non-diabetes mortality (p for linear < 0.0001).
In this study, there is a no significant association between high AIP levels and a high risk of all-cause and cardiovascular mortality. Besides, a higher AIP was significantly associated with an increased risk of diabetes mortality, which only found in women older than 65 years. AIP was associated with all-cause mortality in a U-shape. This association could be explained by the finding that higher AIP predicted a higher risk of death from diabetes, and that lower AIP predicted a higher risk of death from non-diabetes causes.
血浆致动脉粥样硬化指数(AIP)是动脉粥样硬化和心血管疾病(CVD)的标志物。然而,很少有研究调查 AIP 与普通人群全因死亡率和特定死亡率之间的关系。
本研究纳入了 14063 名美国成年人的数据。暴露变量为 AIP,定义为 log10(甘油三酯/高密度脂蛋白胆固醇)。结局变量包括全因死亡率和特定死亡率。采用调查加权 Cox 回归评估 AIP 与全因死亡率和特定死亡率的关系。采用加权限制立方样条分析非线性关系。
在 10 年的随访期间,我们记录了全因死亡率、糖尿病死亡率、CVD 死亡率和癌症死亡率分别为 2077、262、854 和 476 例。在调整了潜在混杂因素后,我们发现与 AIP 最低四分位数相比,血浆致动脉粥样硬化指数(AIP)最高四分位数的女性(趋势检验 P = 0.001)或年龄大于 65 岁的参与者(趋势检验 P = 0.002)患糖尿病死亡的风险显著增加。AIP 与全因死亡率、CVD 死亡率和癌症死亡率无显著相关性(P > 0.05)。此外,AIP 与全因死亡率之间呈 U 形的非线性关联(非线性 P = 0.0011),而与非糖尿病死亡率呈线性关联(线性 P < 0.0001)。
在这项研究中,高 AIP 水平与全因和心血管死亡率升高之间没有显著关联。此外,较高的 AIP 与糖尿病死亡率升高显著相关,仅在年龄大于 65 岁的女性中发现。AIP 与全因死亡率呈 U 形相关。这种关联可以用以下发现来解释:较高的 AIP 预示着死于糖尿病的风险更高,而较低的 AIP 预示着死于非糖尿病原因的风险更高。